Search Results Search Sort by RelevanceMost Recent Viewpoint Sep 2023 What Should Clinicians Know About Palliative Psychopharmacology? Awais Aftab, MD This article examines conceptual limitations of extant accounts of palliative psychiatry, with a focus on obligations to distinguish among and clearly formulate goals of care. AMA J Ethics. 2023;25(9):E710-717. doi: 10.1001/amajethics.2023.710. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Podcast Apr 2024 Ethics Talk: Supply Chain Reasons Your Pharmacy Might Not Have Your Medicine Dr Amy B. Cadwallader joins Ethics Talk to discuss how critical medicine supply chains are identified and secured. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Viewpoint Sep 2023 What Should Clinicians Know About Palliative Psychopharmacology? Awais Aftab, MD This article examines conceptual limitations of extant accounts of palliative psychiatry, with a focus on obligations to distinguish among and clearly formulate goals of care. AMA J Ethics. 2023;25(9):E710-717. doi: 10.1001/amajethics.2023.710.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Podcast Apr 2024 Ethics Talk: Supply Chain Reasons Your Pharmacy Might Not Have Your Medicine Dr Amy B. Cadwallader joins Ethics Talk to discuss how critical medicine supply chains are identified and secured.